Mitophagy in Hepatic Ischemia–Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting
Biomolecules · 24.06.2026 · 16 (7) · 941
DOI: 10.3390/biom16070941 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.06.2026. Verfasst von Xinlei Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Mitophagy, Liver, Mitochondria. Die Arbeit nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatic ischemia–reperfusion injury (HIRI) is a major cause of postoperative liver dysfunction and adverse outcomes in hepatectomy, liver transplantation, and hemorrhagic shock. Among the multiple mechanisms implicated in HIRI, mitochondria are recognized as central organelles that integrate metabolic failure, oxidative stress, inflammation, and cell death. During ischemia, interruption of oxygen and nutrient supply impairs oxidative phosphorylation, depletes ATP, disrupts ionic homeostasis, and renders mitochondria highly vulnerable to subsequent injury. Upon reperfusion, reoxygenation triggers excessive reactive oxygen species production, calcium overload, mitochondrial permeability transition pore opening, and release of damage-associated molecular patterns, thereby amplifying hepatocellular injury and sterile inflammatory responses. As a key component of mitochondrial quality control, mitophagy plays a context-dependent role in HIRI. Appropriate activation of mitophagy facilitates the clearance of damaged mitochondria, limits oxidative stress, restrains inflammasome activation, and preserves hepatocellular homeostasis, whereas insufficient or dysregulated mitophagy contributes to mitochondrial accumulation and aggravates liver injury. This review summarizes mitochondrial alterations during the ischemic and reperfusion phases, outlines the major mitophagy pathways involved in HIRI and discusses recent advances in upstream regulation, disease-specific dysregulation, and mitophagy-targeted interventions. A better understanding of the dynamic and biphasic nature of mitophagy in HIRI may provide a stronger theoretical basis for precision liver-protective strategies and future translational therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zou, X., Zhang, T., Wang, N., Li, Y., Jiang, X., & Zhong, X. (2026). Mitophagy in Hepatic Ischemia–Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting. Biomolecules, 16(7), 941. https://doi.org/10.3390/biom16070941
Vancouver
Zou X, Zhang T, Wang N, Li Y, Jiang X, Zhong X. Mitophagy in Hepatic Ischemia–Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting. Biomolecules. 2026;16(7):941. doi:10.3390/biom16070941
BibTeX
@article{Zou2026,
author = {Zou, Xinlei and Zhang, Tianjie and Wang, Nan and Li, Yuanyue and Jiang, Xingming and Zhong, Xiangyu},
title = {Mitophagy in Hepatic Ischemia–Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {941},
doi = {10.3390/biom16070941}
}
EUVIMED